Therefore, in this study, we first aimed to find a Parkinson’s disease family protein that is differentially expressed in colon cancer and normal tissue, and we were able to identify cation-transporting ATPase 13A2 (ATP13A2) as a putative biomarker for colon cancer. This evidence concerns the gene ATP13A2 and colonic neoplasm.